These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9698490)

  • 1. The antiestrogen tamoxifen in the treatment of recurrent benign cystic mesothelioma.
    Letterie GS; Yon JL
    Gynecol Oncol; 1998 Jul; 70(1):131-3. PubMed ID: 9698490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrent benign cystic peritoneal mesothelioma].
    Stroescu C; Negulescu R; Herlea V; David L; Ivanov B; Nitipir C; Popescu I
    Chirurgia (Bucur); 2008; 103(6):715-8. PubMed ID: 19274921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
    Markman M; Webster K; Zanotti K; Rohl J; Belinson J
    Gynecol Oncol; 2004 May; 93(2):390-3. PubMed ID: 15099951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy.
    Molpus KL; Wu H; Fuller AF
    Gynecol Oncol; 1998 Feb; 68(2):206-9. PubMed ID: 9514798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a long-acting GnRH agonist for benign cystic mesothelioma.
    Letterie GS; Yon JL
    Obstet Gynecol; 1995 May; 85(5 Pt 2):901-3. PubMed ID: 7724156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of "benign" cystic mesothelioma of the peritoneum.
    González-Moreno S; Yan H; Alcorn KW; Sugarbaker PH
    J Surg Oncol; 2002 Apr; 79(4):243-51. PubMed ID: 11920782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign cystic mesothelioma with multiple recurrences: a clinical case].
    Bruni R; Nigita G; Pagani V; Bonaiuti G; Petrocca S; Terenzi A
    Chir Ital; 2003; 55(5):757-60. PubMed ID: 14587121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Lee JH; Recht A
    J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign cystic mesothelioma, a rare tumor of the peritoneum].
    Szöllósi A; Ferenc C; Pintér T; Erényi A; Nagy A
    Magy Seb; 2005 Feb; 58(1):35-7. PubMed ID: 16018599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
    Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
    J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status.
    Sawh RN; Malpica A; Deavers MT; Liu J; Silva EG
    Hum Pathol; 2003 Apr; 34(4):369-74. PubMed ID: 12733118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
    Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization and regression of a recurrent desmoid tumor with the antiestrogen toremifene.
    Maseelall P; Robins JC; Williams DB; Thomas MA
    Fertil Steril; 2005 Aug; 84(2):509. PubMed ID: 16086575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign cystic mesothelioma in a male patient: surgical treatment by the laparoscopic route.
    Ricci F; Borzellino G; Ghimenton C; Cordiano C
    Surg Laparosc Endosc; 1995 Apr; 5(2):157-60. PubMed ID: 7773468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cystic mesothelioma.
    Vara-Thorbeck C; Toscano-Mendez R
    Surg Endosc; 2002 Jan; 16(1):220. PubMed ID: 11961660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.